1. Home
  2. PRTA vs VHI Comparison

PRTA vs VHI Comparison

Compare PRTA & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • VHI
  • Stock Information
  • Founded
  • PRTA 2012
  • VHI 1932
  • Country
  • PRTA Ireland
  • VHI United States
  • Employees
  • PRTA N/A
  • VHI N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • VHI Major Chemicals
  • Sector
  • PRTA Health Care
  • VHI Industrials
  • Exchange
  • PRTA Nasdaq
  • VHI Nasdaq
  • Market Cap
  • PRTA 643.0M
  • VHI 709.1M
  • IPO Year
  • PRTA N/A
  • VHI N/A
  • Fundamental
  • Price
  • PRTA $13.77
  • VHI $23.98
  • Analyst Decision
  • PRTA Buy
  • VHI Sell
  • Analyst Count
  • PRTA 7
  • VHI 1
  • Target Price
  • PRTA $46.50
  • VHI $20.00
  • AVG Volume (30 Days)
  • PRTA 711.1K
  • VHI 21.0K
  • Earning Date
  • PRTA 02-13-2025
  • VHI 03-06-2025
  • Dividend Yield
  • PRTA N/A
  • VHI 1.33%
  • EPS Growth
  • PRTA N/A
  • VHI N/A
  • EPS
  • PRTA N/A
  • VHI 3.08
  • Revenue
  • PRTA $133,350,000.00
  • VHI $2,076,900,000.00
  • Revenue This Year
  • PRTA $56.89
  • VHI $19.58
  • Revenue Next Year
  • PRTA N/A
  • VHI $11.92
  • P/E Ratio
  • PRTA N/A
  • VHI $7.80
  • Revenue Growth
  • PRTA N/A
  • VHI 10.99
  • 52 Week Low
  • PRTA $11.70
  • VHI $12.12
  • 52 Week High
  • PRTA $34.75
  • VHI $41.75
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 48.19
  • VHI 54.07
  • Support Level
  • PRTA $12.39
  • VHI $20.40
  • Resistance Level
  • PRTA $13.64
  • VHI $23.31
  • Average True Range (ATR)
  • PRTA 1.03
  • VHI 1.20
  • MACD
  • PRTA -0.02
  • VHI 0.39
  • Stochastic Oscillator
  • PRTA 40.47
  • VHI 86.27

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.

Share on Social Networks: